Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2013-05-10

FDA Approved: LEVALBUTEROL — Supplemental Application (Mylan Pharmaceuticals Inc.)

View source ↗

Summary

FDA grants supplemental approval for a generic levalbuterol product from Mylan Pharmaceuticals, enabling market entry of a generic inhaled bronchodilator for re…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Levalbuterol (Levalbuterol)

Snippet

SUPPL AP for LEVALBUTEROL (LEVALBUTEROL)